Reply to Harrington et al
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Reply to Harrington et al
  • Published Date:

    Aug 19 2015

  • Source:
    J Infect Dis. 213(3):497-498.
Filetype[PDF-53.40 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 31.27 KB]
    Personal Author:
    Gutman, Julie; Eckert, Erin; Mangiaterra, Viviana; Bardají, Azucena; Aponte, John J; Menéndez, Clara; Nahlen, Bernard; Slutsker, Laurence;
    Published Date:
    Apr 2013
    Source:
    Lancet Infect Dis. 13(4):292.
    File Type:
    Filetype[PDF - 31.27 KB]
  2. Filetype[PDF - 799.46 KB]
    Personal Author:
    Gutman, Julie; Mwandama, Dyson; Wiegand, Ryan E; Abdallah, Joseph; Iriemenam, Nnaemeka C; Shi, Ya Ping; Mathanga, Don P; Skarbinski, Jacek;
    Published Date:
    May 13 2015
    Source:
    Malar J. 14.
    Description:
    BackgroundThe effectiveness of sulphadoxine-pyrimethamine (SP) intermittent preventive treatment of malaria in pregnancy (IPTp) might be compromised by high prevalence of resistance-associated Plasmodium falciparum dihydrofolate reductase (dhfr) and ...
    File Type:
    Filetype[PDF - 799.46 KB]
  3. Filetype[PDF - 1.39 MB]
    Personal Author:
    Sridaran, Sankar; McClintock, Shannon K; Syphard, Luke M; Herman, Karen M; Barnwell, John W; Udhayakumar, Venkatachalam;
    Published Date:
    Aug 30 2010
    Source:
    Malar J. 2010; 9:247.
    Description:
    BackgroundMutations in the dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) genes of Plasmodium falciparum are associated with resistance to anti-folate drugs, most notably sulphadoxine-pyrimethamine (SP). Molecular studies document...
    File Type:
    Filetype[PDF - 1.39 MB]
  4. Filetype[PDF - 1.44 MB]
    Personal Author:
    Rogier, Eric; Herman, Camelia; Huber, Curtis S.; Hamre, Karen E.S.; Pierre, Baby; Mace, Kimberly E.; Présumé, Jacquelin; Mondélus, Gina; Romilus, Ithamare; Elismé, Tamara; Eisele, Thomas P.; Druetz, Thomas; Existe, Alexandre; Boncy, Jacques; Lemoine, Jean F.; Udhayakumar, Venkatachalam; Chang, Michelle A.;
    Published Date:
    May 2020
    Source:
    Emerg Infect Dis. 26(5):902-909
    Description:
    Haiti is striving for zero local malaria transmission by the year 2025. Chloroquine remains the first-line treatment, and sulfadoxine/pyrimethamine (SP) has been used for mass drug-administration pilot programs. In March 2016, nationwide molecular su...
    File Type:
    Filetype[PDF - 1.44 MB]
  5. Filetype[PDF - 1.30 MB]
    Personal Author:
    Iriemenam, Nnaemeka C; Shah, Monica; Gatei, Wangeci; van Eijk, Anna M; Ayisi, John; Kariuki, Simon; Vanden Eng, Jodi; Owino, Simon O; Lal, Ashima A; Omosun, Yusuf O; Otieno, Kephas; Desai, Meghna; ter Kuile, Feiko O; Nahlen, Bernard; Moore, Julie; Hamel, Mary J; Ouma, Peter; Slutsker, Laurence; Shi, Ya Ping;
    Published Date:
    July 04 2012
    Source:
    Malar J. 2012; 11:134
    Description:
    BackgroundResistance to sulphadoxine-pyrimethamine (SP) in Plasmodium falciparum parasites is associated with mutations in the dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) genes and has spread worldwide. SP remains the recommend...
    File Type:
    Filetype[PDF - 1.30 MB]